A number of studies have shown that statins, which inhibit the rate‐limiting enzyme of the MVA pathway, 3‐hydroxy‐3‐methylglutaryl‐CoA reductase (HMGCR), exhibit anti‐cancer effects in many cancers by reducing isoprenoids (Yu et al, 2018). The gene discussed is HMGCR; the disease is cancer.